Sökning: id:"swepub:oai:lup.lub.lu.se:7275811f-6dfe-4242-bf91-1fa8d46bddad" >
European Society of...
European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination : 2023 revision
-
- Schiaffino, Simone (författare)
- Regional Hospital of Lugano
-
- Pinker, Katja (författare)
- Memorial Sloan-Kettering Cancer Center,Medical University of Vienna
-
- Cozzi, Andrea (författare)
- Regional Hospital of Lugano
-
visa fler...
-
Magni, Veronica (författare)
-
- Athanasiou, Alexandra (författare)
- Hospital MITERA
-
- Baltzer, Pascal A.T. (författare)
- Medical University of Vienna
-
Camps Herrero, Julia (författare)
-
- Clauser, Paola (författare)
- Medical University of Vienna
-
- Fallenberg, Eva M. (författare)
- Klinikum rechts der Isar
-
- Forrai, Gabor (författare)
- Duna Medical Center
-
- Fuchsjäger, Michael H. (författare)
- Medical University of Graz
-
Gilbert, Fiona J. (författare)
-
- Helbich, Thomas (författare)
- Medical University of Vienna
-
Kilburn-Toppin, Fleur (författare)
-
- Kuhl, Christiane K. (författare)
- Universitätsklinikum der RWTH Aachen
-
- Lesaru, Mihai (författare)
- Fundeni Clinical Institute
-
- Mann, Ritse M. (författare)
- Radboud University Medical Center,Antoni Van Leeuwenhoek Hospital
-
- Panizza, Pietro (författare)
- San Raffaele Hospital
-
Pediconi, Federica (författare)
-
- Sardanelli, Francesco (författare)
- Policlinico San Donato University Hospital
-
- Sella, Tamar (författare)
- Hadassah University Hospital
-
- Thomassin-Naggara, Isabelle (författare)
- Hopital Tenon
-
- Zackrisson, Sophia (författare)
- Lund University,Lunds universitet,Diagnostisk radiologi, Malmö,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,LTH profilområde: Avancerade ljuskällor,LTH profilområden,Lunds Tekniska Högskola,LU profilområde: Ljus och material,Lunds universitets profilområden,Radiology Diagnostics, Malmö,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,LTH Profile Area: Photon Science and Technology,LTH Profile areas,Faculty of Engineering, LTH,LU Profile Area: Light and Materials,Lund University Profile areas,Skåne University Hospital
-
- Pijnappel, Ruud M. (författare)
- University Medical Center Utrecht
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska.
-
Ingår i: Insights into Imaging. - 1869-4101. ; 14:1
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Axillary lymphadenopathy is a common side effect of COVID-19 vaccination, leading to increased imaging-detected asymptomatic and symptomatic unilateral axillary lymphadenopathy. This has threatened to negatively impact the workflow of breast imaging services, leading to the release of ten recommendations by the European Society of Breast Imaging (EUSOBI) in August 2021. Considering the rapidly changing scenario and data scarcity, these initial recommendations kept a highly conservative approach. As of 2023, according to newly acquired evidence, EUSOBI proposes the following updates, in order to reduce unnecessary examinations and avoid delaying necessary examinations. First, recommendation n. 3 has been revised to state that breast examinations should not be delayed or rescheduled because of COVID-19 vaccination, as evidence from the first pandemic waves highlights how delayed or missed screening tests have a negative effect on breast cancer morbidity and mortality, and that there is a near-zero risk of subsequent malignant findings in asymptomatic patients who have unilateral lymphadenopathy and no suspicious breast findings. Second, recommendation n. 7 has been revised to simplify follow-up strategies: in patients without breast cancer history and no imaging findings suspicious for cancer, symptomatic and asymptomatic imaging-detected unilateral lymphadenopathy on the same side of recent COVID-19 vaccination (within 12 weeks) should be classified as a benign finding (BI-RADS 2) and no further work-up should be pursued. All other recommendations issued by EUSOBI in 2021 remain valid.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- COVID-19 vaccines
- Lymphadenopathy
- Magnetic resonance imaging
- Mammography
- Ultrasonography (breast)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Schiaffino, Simo ...
-
Pinker, Katja
-
Cozzi, Andrea
-
Magni, Veronica
-
Athanasiou, Alex ...
-
Baltzer, Pascal ...
-
visa fler...
-
Camps Herrero, J ...
-
Clauser, Paola
-
Fallenberg, Eva ...
-
Forrai, Gabor
-
Fuchsjäger, Mich ...
-
Gilbert, Fiona J ...
-
Helbich, Thomas
-
Kilburn-Toppin, ...
-
Kuhl, Christiane ...
-
Lesaru, Mihai
-
Mann, Ritse M.
-
Panizza, Pietro
-
Pediconi, Federi ...
-
Sardanelli, Fran ...
-
Sella, Tamar
-
Thomassin-Naggar ...
-
Zackrisson, Soph ...
-
Pijnappel, Ruud ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Insights into Im ...
- Av lärosätet
-
Lunds universitet